Immune Checkpoint Inhibitors in Organ Transplant Patients
2017
Modulation of T-cell activity through blockade of coinhibitory molecules has revolutionized the treatment of various malignancies. Several immune checkpoint inhibitors are currently Food and Drug Administration approved which target various coinhibitory pathways including cytotoxic T-lymphocyte-asso
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
78
Citations
NaN
KQI